COMPARISON OF THE DRUGS ASSORTMENT THAT USED FOR THE NOSE CAVITY DISEASES TREATMENT IN UKRAINE AND POLAND
DOI:
https://doi.org/10.11603/2312-0967.2022.3.13343Keywords:
pharmaceutical market, dosage form, active pharmaceutical ingredient, diseases of the nasal cavityAbstract
The aim of the work. To conduct a study of the assortment of drugs of the R01 group on the pharmaceutical markets of Ukraine and Poland and to analyze the possibility of conducting pharmacotherapy of diseases of the nasal cavity to citizens of Ukraine who are temporarily staying in the territory of a neighboring European country.
Materials and Methods. The work was performed using official sources of information, data from which were processed, systematized using statistical, logical and graphical methods.
Results and Discussion. As a result of the analysis, it was found that in the pharmaceutical markets of Ukraine and Poland, registered drugs for the treatment of nasal cavity are most often used in the form of a spray – 62.25 % and 66.67 %, respectively. According to the number of active pharmaceutical ingredients of drugs of group R01 can be placed in a descending series of sympathomimetics 〉corticosteroids 〉antihistamines. Both pharmaceutical markets are dominated by single-component drugs. The Polish pharmaceutical market of drugs for the treatment of nasal cavity is represented mostly by products of its own production, and Ukrainian - by imported medicines. Farmak JSC is the leader among domestic manufacturers of R 01 group medicines on the Ukrainian market.
Conclusions. Pharmaceutical markets of Ukraine and Poland are similar in range of drugs of group R01. Despite some differences in the nomenclature of drugs and manufacturers, drugs for the treatment of the nasal cavity are represented by identical substances, which makes it possible to conduct optimal pharmacotherapy in both countries.
References
Candidate status for EU membership: challenges and opportunities for the pharmaceutical market of Ukraine. Available from: https://www.apteka.ua/article/639768
Healthcare Development Strategy until 2030: expectations and priorities. Available from: https://www.apteka.ua/article/625280
State Register of Medicines of Ukraine. [Державний реєстр лікарських засобів України] Available from: http://www.drlz.kiev.ua/ Ukrainian.
State Register of Medicines of Poland. Available from: https://rejestrymedyczne.ezdrowie.gov.pl/rpl/search/public
Parashchyn ZhD, Lobur IP, Kirichuk AO, Brida OR, Stadnytska NYe. Study of the composition of drugs for the treatment of diseases of the nose cavity. Chemistry, Technology and Application of Substances. 2021;4(2): 54-63. doi:10.23939/ctas2021.02.054
Compendium Directory [Internet]. Available from: http://compendium.com.ua.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pharmaceutical Review / Farmacevtičnij časopis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
